Eloxx is a Massachusetts-based biopharmaceutical company that researches and develops RNA-targeted genetic therapies for the treatment of premature stop codon diseases.
Business Model:
Revenue: $3.6M
Employees: 11-50
Address: 480 Arsenal Way
City: Watertown
State: MA
Zip: 02472
Country: US
Eloxx is a Massachusetts-based biopharmaceutical company that researches and develops RNA-targeted genetic therapies for the treatment of premature stop codon diseases.
Contact Phone:
+17815775300
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
4/26/2018
Ticker Symbol:
ELOX
IPO Price:
$9.75/share
Amount Raised:
$50M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Name | Price |
---|---|---|
4/2021 | Zikani Therapeutics | |
6/2017 | Sevion Therapeutics |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|